Idiopathic pulmonary fibrosis (IPF) is a highly heterogeneous, unpredictable and ultimately
lethal chronic lung disease. Over the last decade, two anti-fibrotic agents have been shown …

Recent genetic and genomic advancements have elucidated the complex etiology of
idiopathic pulmonary fibrosis (IPF) and other progressive fibrotic interstitial lung diseases …

Interstitial lung disease (ILD) is a large and heterogeneous group of diseases manifesting
primarily in the distal bronchoalveolar space. Some ILDs have identifiable causes or …

Rationale: Distinguishing connective tissue disease–associated interstitial lung disease
(CTD-ILD) from idiopathic pulmonary fibrosis (IPF) can be clinically challenging. Objectives …

SUMMARY OF KEY POINTS In this review, we have discussed several important
developments in 2023 in Interstitial Lung Disease (ILD). The association of pollution with …

Purpose Determining the cause of interstitial lung disease (ILD) remains challenging. While
surgical lung biopsy remains the gold standard approach, risks associated with it may be …

Fibrosing interstitial lung diseases (ILDs) encompass a diverse range of scarring disorders
that lead to progressive lung failure. Previous gene expression profiling studies focused on …

Background The Envisia Genomic Classifier (EGC) is a clinically validated molecular
diagnostic test identifying usual interstitial pneumonia (UIP), increasing the diagnostic …

The utility of incorporating a usual interstitial pneumonia (UIP) genomic classifier (GC) and
bronchoalveolar lavage (BAL) cell count analysis alongside traditional clinical-imaging …

Abstract Purpose of Review The term interstitial pneumonia with autoimmune features
(IPAF) was proposed by an international task force as a research classification to …